Company Filing History:
Years Active: 1995-1998
Title: Kanaka Raju Koduri: Innovator in Lipoprotein Research
Introduction
Kanaka Raju Koduri is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biochemistry, particularly in the study of lipoproteins. With a total of 2 patents, his work focuses on innovative methods for determining levels of low-density lipoproteins (LDL) in plasma.
Latest Patents
Koduri's latest patents include groundbreaking methods and compositions for assessing LDL levels. One of his notable inventions involves a polypeptide that immunologically mimics native apoprotein B-100 (apo B-100) found in LDL particles. This polypeptide features an amino acid residue sequence that corresponds to a pan epitope region of the target apoprotein. Additionally, he has developed a fusion protein that simultaneously mimics both native apo B-100 and native apo A-I. His improved assay systems and methods enhance the determination of HDL and LDL levels in body fluid samples.
Career Highlights
Kanaka Raju Koduri is affiliated with The Scripps Research Institute, where he continues to advance research in lipoprotein analysis. His innovative approaches have garnered attention in the scientific community, contributing to a better understanding of lipid profiles and their implications for health.
Collaborations
Koduri has collaborated with esteemed colleagues, including Richard S. Smith and Linda K. Curtiss. These partnerships have further enriched his research endeavors and expanded the impact of his work.
Conclusion
Kanaka Raju Koduri stands out as a key figure in lipoprotein research, with his patents paving the way for improved diagnostic methods. His contributions are vital for advancing our understanding of lipid-related health issues.